 | Up a level |
Jalaludin, Muhammad Yazid and Deeb, Asma and Zeitler, Philip and Garcia, Raymundo and Newfield, Ron S. and Samoilova, Yulia and Rosario, Carmen A. and Shehadeh, Naim and Saha, Chandan K. and Zhang, Yilong and Zilli, Martina and Scherer, Lynn W. and Lam, Raymond L. H. and Golm, Gregory T. and Engel, Samuel S. and Kaufman, Keith D. and Shankar, R. Ravi (2022) Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin. Pediatric Diabetes, 23 (2). pp. 183-193. ISSN 1399-543X, DOI https://doi.org/10.1111/pedi.13282.
Shankar, R. Ravi and Zeitler, Philip and Deeb, Asma and Jalaludin, Muhammad Yazid and Garcia, Raymundo and Newfield, Ron S. and Samoilova, Yulia and Rosario, Carmen A. and Shehadeh, Naim and Saha, Chandan K. and Zhang, Yilong and Zilli, Martina and Scherer, Lynn W. and Lam, Raymond L. H. and Golm, Gregory T. and Engel, Samuel S. and Kaufman, Keith D. (2022) A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes. Pediatric Diabetes, 23 (2). pp. 173-182. ISSN 1399-543X, DOI https://doi.org/10.1111/pedi.13279.
